Quijano, Mile Jhon .
HRN: 23-46-20 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/31/2023
CEFUROXIME 750MG (VIAL)
07/31/2023
08/07/2023
IVTT
250mg
Q8
PCAP.
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes